Gibson Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Hold
2,431
0.04% 81
2026
Q1
$235K Buy
2,431
+101
+4% +$10.4K 0.04% 78
2025
Q4
$247K Sell
2,330
-127
-5% -$14.7K 0.05% 74
2025
Q3
$312K Hold
2,457
0.06% 64
2025
Q2
$301K Hold
2,457
0.06% 57
2025
Q1
$249K Hold
2,457
0.05% 67
2024
Q4
$227K Hold
2,457
0.05% 65
2024
Q3
$237K Hold
2,457
0.05% 62
2024
Q2
$211K Hold
2,457
0.05% 62
2024
Q1
$203K Buy
+2,457
New +$180K 0.04% 67
2021
Q2
Sell
-3,088
Closed -$200K 41
2021
Q1
$200K Hold
3,088
0.06% 41
2020
Q4
$203K Buy
+3,088
New +$182K 0.06% 36

Other funds holding EHC

Gibson Capital's EHC Position: Q2 2026 in Review

Gibson Capital held its Encompass Health (EHC) position steady in Q2 2026 at 2,431 shares worth $246K. The position accounts for 0.04% of the portfolio, ranked #81.

Gibson Capital first reported a position in EHC in Q4 2020 and has held it in 12 quarters since. The position peaked at $312K in Q3 2025. 472 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Gibson Capital held 2,431 shares of Encompass Health worth $246K as of Q2 2026.
  • Gibson Capital left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up 0.04% of Gibson Capital's portfolio in Q2 2026, its #81 holding.
  • Gibson Capital first reported a position in Encompass Health in Q4 2020 and has held it in 12 quarters since.
  • Gibson Capital's Encompass Health position peaked at $312K in Q3 2025.
  • 472 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Gibson Capital's 13F filing for Q2 2026, filed 13 Aug 2026.